| dc.contributor.author | Ozdogan, Huri | |
| dc.contributor.author | Kasapcopur, Ozgur | |
| dc.contributor.author | SEVGI, Serhan | |
| dc.contributor.author | Ugurlu, Serdal | |
| dc.contributor.author | Erer, Burak | |
| dc.contributor.author | Gül, Ahmet | |
| dc.contributor.author | Davis, Nicole | |
| dc.date.accessioned | 2021-03-05T20:56:09Z | |
| dc.date.available | 2021-03-05T20:56:09Z | |
| dc.identifier.citation | Gül A., Ozdogan H., Erer B., Ugurlu S., Kasapcopur O., Davis N., SEVGI S., "Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever", ARTHRITIS RESEARCH & THERAPY, cilt.17, 2015 | |
| dc.identifier.issn | 1478-6354 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_d6816742-c772-48d1-b9d1-0322c17153e4 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/141550 | |
| dc.identifier.uri | https://doi.org/10.1186/s13075-015-0765-4 | |
| dc.description.abstract | Introduction: This open-label pilot study aimed to investigate the efficacy of canakinumab in colchicine-resistant familial Mediterranean fever (FMF) patients. | |
| dc.language.iso | eng | |
| dc.subject | İmmünoloji ve Romatoloji | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Klinik Tıp | |
| dc.subject | ROMATOLOJİ | |
| dc.title | Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever | |
| dc.type | Makale | |
| dc.relation.journal | ARTHRITIS RESEARCH & THERAPY | |
| dc.contributor.department | İstanbul Teknik Üniversitesi , Fen-Edebiyat , Kimya | |
| dc.identifier.volume | 17 | |
| dc.contributor.firstauthorID | 42466 | |
